866-503-0857. 503 Sunport Lane, Orlando, FL 32809. Phone: 1-866-503-0857 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) FAX: 1-844-268-7263 Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax:

Persoonlijke. migraine zorg. Bij The Migraine Clinic begrijpen we dat migraine meer is dan alleen hoofdpijn. Het is een ingrijpende aandoening die je leven kan beïnvloeden. Zet …

866-503-0857. MEDICARE FORM. Viscosupplementation Injectable Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) Patient Last Name. Patient Phone. For Medicare Advantage Part B: Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263. For other lines of business: Please use other form.

1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /

1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 Page 2 of 2 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . Breast implant associated anaplastic large cell lymphoma, Cutaneous anaplastic large cell lymphoma, Systemic anaplastic large cell lymphoma (ALCL)

MEDICARE FORM. Viscosupplementation Injectable Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) Patient Last Name. Patient Phone. For Medicare Advantage Part B: Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263. For other lines of business: Please use other form.1-866-503-0857 . For other lines of business: Please use other form. Note: Fulphila, Nyvepria and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Udenyca are preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last ...Drug: Humira® (adalimumab inj kit) Note: Precertification review for this medication is handled by Aetna Pharmacy Management Precertification at 1-855-240-0535 or fax applicable request forms to 1-877-269-9916. Exception: Requests for drugs administered by a healthcare professional that will be billed to the medical plan, call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277.859-455-8650. CoverMyMeds – Pre-Authorization. 866-503-0857. CoverMyMeds – General Information. 866-452-5017. Aetna Coventry (Workers Compensation and Auto Injury) 800-937-6824. Discover Aetna provider phone numbers. Simplify interactions and access support promptly with accurate and up-to-date contact information.Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date. Continuation of therapy, Date of last treatment . Precertification Requested By: Phone: Fax:Aetna Precertification Notification Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment. ...1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /For Male Members: Bravelle, Follistim AQ, Gonal-F, Gonal-F RFF, Menopur, Repronex. A documented diagnosis of use with human chorionic gonadotropin (hCG) for the induction of spermatogenesis in men with primary or secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure AND; A documented contraindication or intolerance or allergy or ...PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Susvimo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use.

: 1-866-503-0857 . FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Aralast NP, Glassia and Zemaira are non-preferred. The preferred product is Prolastin-C. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of ...1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-866-503-0857 . For other lines of business: Please use other form. Note: Fulphila, Nyvepria and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Udenyca are preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last ...According to the CIA, as of 2018 there were an estimated 981,129,427 boys ages 0 to 14 living in the world. This number stems from an estimated total population of 7,503,828,180. Y...

1-866-503-0857 . For other lines of business: Please use other form. Note: Abraxane is non-preferred. The preferred products are docetaxel or paclitaxel. Docetaxel and paclitaxel do not require precertification. (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date / /

Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 For other lines of business: Please use other form. Note: Fylnetra, Nyvepria, Rolvedon, Stimufend, Udenyca and Udenyca Onbody are non-preferred. Fulphila and Neulasta/Neulasta Onpro are preferred. (All fields must be completed and legible for precertification review.) Patient First Name

The PeopleFinders phone number lookup gives you all the information you need about an unknown caller. Our complete phone number directory is always up-to-date. Plus, our easy-to-use site gives you instant results, making your reverse phone search as convenient as it is helpful. Find the name, address, and other pertinent background info about a phone …HOTCHKIS & WILEY VALUE OPPORTUNITIES FUND CLASS A- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies Stocks1-866-503-0857 For other lines of business: Please use other form. Note: Fulphila, Nyvepria, and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Udenyca are preferred. G. CLINICAL INFORMATION (continued) – Required clinical information must be completed in its entirety for all precertification requests. For Initiation requests:1-866-752-7021 . FAX: 1-888-267-3277 . Page 1 of 1 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax:1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)

Phone: 1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment .1-866-752-7021. FAX: 1-888-267-3277. For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax: A. PATIENT ...Phone: 1-866-503-0857. FAX: 1-844-268-7263. Patient First Name. Patient Last Name. Patient Phone. Patient DOB. G. CLINICAL INFORMATION (continued) – Required clinical information must be completed in its entirety for all precertification requests.Need a magento development company in the United Kingdom? Read reviews & compare projects by leading magento designers. Find a company today! Development Most Popular Emerging Tech...GR-69025-CA (10-14) Page 1New 08/13 of 2 PRESCRIPTION DRUG PRIOR AUTHORIZATION REQUEST FORM Instructions: Please fill out all applicable sections on both pages completely and legibly . Attach any additional documentation that isPHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Vabysmo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. Patient First Name . Patient Last NamePhone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / / Precertification Requested By: Phone: Fax:Perform a reverse number lookup and you will be able to identify who’s behind the call and decide if you should return the call or not. Connect with a long-lost friend. Through a free reserve phone number lookup, you can re-establish contact with a relative, friend from high school, former work colleague, or associate. Run a background check.Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment. Precertification Requested By: / / Phone: For Medicare Advantage Part B: FAX: 1-844-268-7263 Phone: 1-866-503-0857. For other lines of business: Please use other form. Note: Zoladex is non-preferred. The preferred product is Eligard.PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lupron Depot is non-preferred. The preferred product Page 1 of 3 is Eligard. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / /Fasenra® (benralizumab) Injectable Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Patient First Name.1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 . Page 2 of 2 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)1-866-752-7021 acetate for depot suspension) FAX: 1-888-267-3277 Medication Precertification Request For Medicare Advantage Part B: Phone: 1-866-503-0857 Page 2 of 2 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . H. …Aetna Precertification Notification Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment. Precertification ...Weeds are noxious, persistent plants that destroy lawns and gardens. Identify your landscape’s pesky invaders with this list of the worst weeds in each state. Expert Advice On Impr...Medication Precertification Request . FAX: 1-888-267-3277. Page 1 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263. Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /Video instructions and help with filling out and completing 866 503 0857 Form. Find a suitable template on the Internet. Read all the field labels carefully. Start filling out the blanks according to the instructions: Instructions and help …Therefore, the airSlate SignNow web application is a must-have for completing and signing 866 503 0857 on the go. In a matter of seconds, receive an electronic document with a legally-binding eSignature. Get 866 752 7021 signed right from your smartphone using these six tips: Type signnow.com in your phone’s browser and log in to your account.

The BBB established SRS's profile page in 2005. SRS is listed as a collection agency that uses the alternate business name, Southwest Financial Services. Buzzfile estimates Southwest Recovery Services' annual revenue at $86,735 and the size of its headquarters staff at 2 employees. According to its website, Southwest Recovery Services "is ...Reverse phone lookup for (866) 503-0857. Find full name, address, email, and photos for owner of (866) 503-0857 with Spokeo.Synagis™ (palivizumab ) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Refer to Medical CPB #0318 Synagis (Palivizumab) Policy: Precertification Criteria. Under some plans, including plans that use an open or closed formulary, Synagis is subject to precertification.1-866-503-0857 . For other lines of business: Please use other form . Note: Signifor LAR is non-preferred for acromegaly. The preferred products are Sandostatin LAR and Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy, Date of last ...1-866-503-0857 . or fax applicable request forms to . 1-888-267-3277, with the following exceptions: • For precertification of pharmacy-covered specialtydrugs (noted with*) when memberis enrolled in a commercial plan, call . 1-855-240-0535 . or fax applicable request forms to . 1-877-269-9916 • Providers can use the drug-specificRemicade® (infliximab) Injectable Medication Precertification Request. Page 1 of 5. (All fields must be completed and legible for precertification review.) FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form. Note: Remicade is preferred for MA plans. Preferred status for.

1-866-503-0857. Or fax applicable request forms to . 1-888-267-3277. 9. Dorsal column (lumbar) neurostimulators: trial or implantation ... For the followingservices,providers call1-866-503-0857orfax applicable request forms to 1-888-267-3277,withthe following exceptions: • Forprecertificationof pharmacy -coveredspecialtydrugs(notedwith ...Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 For other lines of business: Please use other form. Note: Fylnetra, Nyvepria, Rolvedon, Stimufend, Udenyca and Udenyca Onbody are non-preferred. Fulphila and Neulasta/Neulasta Onpro are preferred. (All fields must be completed and legible for precertification review.) Patient First Name1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 G. CLINICAL INFORMATION (continued)Repository (H.P. Gel) Aetna Precertification Notification 503 Sunport Lane Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 Medication Precertification Request (All fields must be completed. How It Works. Open form follow the instructions. Easily sign the form with your finger1-866-752-7021 . Sandostatin, Sandostatin LAR Depot . FAX: 1-888-267-3277 . or Bynfezia Pen . For Medicare Advantage Part B: Phone: 1-866-503-0857 . Medication Precertification Request . FAX: 1-844-268-7263 . Page 3 of 3 (All fields must be completed and legible for precertification review) - Patient First Name . Patient Last Name . Patient ...1-866-503-0857 . For other lines of business: Please use other form. Note: Renflexis is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-866-752-7021 . Sandostatin, Sandostatin LAR Depot . FAX: 1-888-267-3277 . or Bynfezia Pen . For Medicare Advantage Part B: Phone: 1-866-503-0857 . Medication Precertification Request . FAX: 1-844-268-7263 . Page 3 of 3 (All fields must be completed and legible for precertification review) - Patient First Name . Patient Last Name . Patient ...For members: call 855-784-8646 and ask for precert dept For providers: 888-632-3862 Aetna Drug Precert: Specialty:866-503-0857 Other: 855-240-0535 OptumRx or Briova: See next page. PHARMACY PRECERTIFICATION: BEFORE 2019--See Aetna pharmacy links ON OR AFTER 1/1/2019--See OptumRx pharmacy links. PRECERTIFICATION LIST IN PLAN:Note: Required Precertification: Precertification of crizanlizumab-tmca (Adakveo) is required of all Aetna participating providers and members in applicable plan designs. For precertification of crizanlizumab-tmca (Adakveo), call (866) 752-7021 or fax (888) 267-3277. For Statement of Medical Necessity (SMN) precertification forms, see Specialty ...Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . Reactive Arthritis (Reiter’s syndrome) Yes . Was the treatment with methotrexate ineffective? Please indicate length of therapy: Less than 1 month . 1 month . 2 months . 3 months or greater . No . YesDrug: Otezla® (apremilast) Note: Precertification review for this medication is handled by Aetna Pharmacy Management Precertification at 1-855-240-0535 or fax applicable request forms to 1-877-269-9916. Exception: Requests for drugs administered by a healthcare professional that will be billed to the medical plan, call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277.For Medicare Part B plans, call (866) 503-0857, or fax (844) 268-7263. Hepatitis B Immune Globulin. Criteria for Initial Approval. Aetna considers hepatitis B immune globulin medically necessary for members who have had contact with an individual diagnosed with hepatitis B virus (HBV). Risk groups include infants born to hepatitis B surface ...GR-69025-CA (10-14) Page 1New 08/13 of 2 PRESCRIPTION DRUG PRIOR AUTHORIZATION REQUEST FORM Instructions: Please fill out all applicable sections on both pages completely and legibly . Attach any additional documentation that is1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /To pre-certify these drugs call 1-866-503-0857 or fax precertification request form to 1-888-267-3277. ...Activity (866) 530-0857. Tags For (866) 530-0857. #Credit One Bank (13) #Bank one credit (1) #Credit One (1) Caller Location: USA Folks are talking about our highly rated call blocking app . Pretty nice Blocked 5 calls from the same telemarketers in one day, great app. - Android Market User

1-866-752-7021 . Sandostatin, Sandostatin LAR Depot . FAX: 1-888-267-3277 . or Bynfezia Pen . For Medicare Advantage Part B: Phone: 1-866-503-0857 . Medication Precertification Request . FAX: 1-844-268-7263 . Page 3 of 3 (All fields must be completed and legible for precertification review) - Patient First Name . Patient Last Name . Patient ...

1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 . Page 2 of 2 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)

1-866-368-5463 www.dmv.state.va.us Disability Assistance Department for Aging & 6340 Center Dr. Bldg 7, Ste 101 (757)451-7101 www.vadrs.org * ... 503 15th St. Virginia Beach, VA 23451 (Appt. Only) (757)962-3567 www.pinministry.org St. Mark's Catholic Church 1505 Kempsville Rd.1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . Breast implant associated anaplastic large cell lymphoma, Cutaneous anaplastic large cell lymphoma, Systemic anaplastic large cell lymphoma (ALCL)Obesity means weighing more than what is healthy for a given height. Obesity is a serious, chronic disease. It can lead to other health problems, including diabetes, heart disease,...Some plans have limited or no out-ofnetwork benefits. Dental implants. Dialysis visits. When a participating provider initiates request, and dialysis is to be performed at a nonparticipating facility, call 1-866-503-0857. Or fax applicable request forms to. 1-888-267-3277. Dorsal column (lumbar) neurostimulators: trial or implantation.Policy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Intravenous Immunoglobulins (IVIG) and Adagen are subject to Precertification. If Precertification requirements apply Aetna considers these medications to be medically necessary for those members who meet the following precertification criteria: (see also Appendix A)1-866-503-0857 . For other lines of business: Please use other form. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION First Name: Last Name: DOB: Address ...1-866-752-7021. FAX: 1-888-267-3277. For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, / / start date: Continuation of therapy,De wijkraad zetelt in de Blinkert en voorlichtingsavonden of het stembureau vinden bijna als vanzelfsprekend op deze locatie plaats. Bij De Blinkert staan 75 aanleunwoningen. De …MEDICARE FORM Stelara®(ustekinumab) Specialty Medication Precertification Request. For Medicare Advantage Part B: FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form. Note: Stelara is non-preferred.

chiz cabssellsword twinblades buildmarathon water tempaldi weekly ad blairsville ga 866-503-0857 vaughn vreeland partner [email protected] & Mobile Support 1-888-750-7066 Domestic Sales 1-800-221-2629 International Sales 1-800-241-8666 Packages 1-800-800-3955 Representatives 1-800-323-7655 Assistance 1-404-209-2683. 1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name. fame diner maspeth queens Fasenra® (benralizumab) Injectable Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Patient First Name.Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, start date: / / Continuation of therapy, date of last treatment: / / Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION First Name: Last Name: Address: City: ... 46782 textblack sclera contact lenses amazon 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263 Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION – Required clinical information must be completed in its entirety for all precertification requests. flordia man march 12cracker barrel morristown New Customers Can Take an Extra 30% off. There are a wide variety of options. Specialty Pharmacy Clinical Policy Bulletins. Aetna Non-Medicare Prescription Drug Plan. Subject: Remicade. Drug. Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service ...1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ...Policy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Bravelle, Cetrotide, chorionic gonadotropin, Follistim AQ, Ganirelix AC, Gonal-F/Gonal-F RFF, Menopur, novarel, Ovidrel, and pregnyl, are subject to precertification.If precertification requirements apply, Aetna considers these medications to be medically necessary for those members who ...